The Ustekinumab Market is segmented by various end-users, each playing a crucial role in the drug's distribution and administration. Hospitals and specialty clinics are the primary end-users, as they have the infrastructure and expertise to administer complex biologic therapies. Many patients, particularly those starting treatment or receiving intravenous infusions for conditions like Crohn's...